RHODDY JONES: Open Payments
NPI 1659401065 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,824 in 162 payments from 12 companies in 2025. Trend: 2023 $1,730 · 2024 $2,831 · 2025 $2,824
Food & beverage: $2,816Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $792 |
| Alkermes, Inc. | 24 | $473 |
| Axsome Therapeutics, Inc. | 16 | $344 |
| Teva Pharmaceuticals USA, Inc. | 30 | $279 |
| Indivior Inc. | 11 | $209 |
| Otsuka America Pharmaceutical, Inc. | 10 | $180 |
| Janssen Pharmaceuticals, Inc | 10 | $178 |
| Lundbeck LLC | 6 | $142 |
| Neurocrine BioSciences, Inc. | 5 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
Products named: VRAYLAR, ARISTADA, Auvelity, UZEDY, REXULTI, SUBLOCADE, INVEGA SUSTENNA, INGREZZA.
Industry payments across MI — which companies pay providers there.
